UK Companies House feature
SMITHKLINE BEECHAM LIMITED
Profile
- Company number
- 02337959
- Status
- Active
- Incorporation
- 1989-01-24
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have taken into account that as part of the Group, the Company has already received the necessary letter of support from GlaxoSmithKline Finance plc and can take actions to ensure business continuity through operational channels, as well as the ability to manage variable costs. On the basis of those considerations, the Directors believe that it remains appropriate to adopt the going concern basis of accounting in preparing the financial statements.”
Subsidiaries
- Beecham Group plc · 100% held · United Kingdom
- Dealcyber Limited · 100% held · United Kingdom
- Eskaylab Limited · 100% held · United Kingdom
- GlaxoSmithKline Capital plc · 100% held · United Kingdom
- GlaxoSmithKline Caribbean Limited · 100% held · United Kingdom
- GlaxoSmithKline (Thailand) Limited · 100% held · Thailand
- SmithKline Beecham (Bangladesh) Private Limited · 50% held · Bangladesh
- SmithKline Beecham (Export) Limited · 100% held · United Kingdom
- SmithKline Beecham (Investments) Limited · 55.04% held · United Kingdom
- SmithKline Beecham Legacy H Limited · 100% held · United Kingdom
- SmithKline Beecham Marketing and Technical Services Limited · 100% held · United Kingdom
- SmithKline Beecham Nominees Limited · 100% held · United Kingdom
- SmithKline Beecham Overseas Limited · 100% held · United Kingdom
- SmithKline Beecham Pension Plan Trustee Limited · 100% held · United Kingdom
- SmithKline Beecham Senior Executive Pension Plan Trustee Limited · 100% held · United Kingdom
- SmithKline & French Laboratories Limited · 100% held · United Kingdom
- The Sydney Ross Co. · 100% held · United States
Significant events
- “SmithKline & French Laboratories Limited (Dissolved on 24 October 2024)”
- “GlaxoSmithKline Consumer Nigeria plc (Dissolved on 25 November 2024)”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 42 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| WHYTE, Victoria Anne | Secretary | 2001-03-29 | — | British |
| OLIINYK, Dmytro | Director | 2022-02-19 | Jun 1983 | Ukrainian |
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Director | 2000-12-31 | — | — |
| GLAXO GROUP LIMITED | Corporate Director | 2000-12-31 | — | — |
Show 42 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BALFOUR, Ian Main Ferguson | Secretary | — | 1993-12-31 |
| BEERY, James Ralph | Secretary | 1994-01-01 | 2001-03-29 |
| BICKNELL, Simon Michael | Secretary | 2001-03-29 | 2011-02-28 |
| HEWITT, Malcolm David | Secretary | 1996-09-06 | 1996-09-06 |
| HORLER, Alison Marie | Secretary | 1996-09-06 | 1996-09-06 |
| MCCLINTOCK, Clare Alexandra | Secretary | 1996-09-06 | 1996-09-06 |
| STEVENS, David John | Secretary | 1991-05-28 | 1995-03-10 |
| ALLAIRE, Paul Arthur | Director | 1993-09-23 | 2000-12-31 |
| BAUMAN, Robert Patten | Director | — | 1994-04-25 |
| BONFIELD, Andrew Robert John | Director | 1999-01-01 | 2000-12-27 |
| BREUEL, Birgit | Director | — | 1992-08-03 |
| BROWNE, Edmund John Phillip, Lord | Director | 1996-06-20 | 1999-10-01 |
| BUXTON, Andrew Robert Fowell | Director | — | 1996-04-29 |
| CLARK, Robert Anthony, Sir | Director | — | 1995-04-24 |
| COLLUM, Hugh Robert | Director | — | 1998-12-31 |
| DINGEMANS, Simon Paul | Director | 2011-04-01 | 2019-05-01 |
| GARNIER, Jean Pierre | Director | 1992-09-28 | 2005-09-01 |
| GOMEZ, Alain | Director | — | 1993-02-19 |
| GRANT, William Robert | Director | — | 1998-04-28 |
| GROOME, Harry Connelly | Director | 1992-06-01 | 1996-04-23 |
| HESLOP, Julian Spenser | Director | 2009-09-09 | 2011-03-31 |
| HOGG, Christopher Anthony, Sir | Director | 1993-02-19 | 2000-12-31 |
| HOOPER, Gloria Dorothy, Baroness | Director | 1994-12-05 | 2000-12-27 |
| HUNTER, John Foster Bray | Director | — | 1992-12-30 |
| LATCHFORD, Richard John | Director | 2021-09-28 | 2022-02-19 |
| LESCHLY, Jan | Director | — | 2000-04-28 |
| LUCIER, Francis Paul | Director | — | 1992-09-28 |
| LYNCH, Ciara Martha | Director | 2020-03-02 | 2020-11-09 |
| MCHENRY, Donald | Director | — | 2000-12-31 |
| PATTESON-BRENT, Erika | Director | 2020-08-25 | 2021-09-17 |
| PFEIFFER JR, Ralph Aloysius | Director | — | 1993-04-26 |
| POSTE, George Henry, Dr | Director | — | 1999-12-31 |
| PROSSER, Ian Maurice Gray, Sir | Director | 1999-08-01 | 2000-12-31 |
| SHAPIRO, Lucy, Dr | Director | 1996-09-22 | 2000-12-31 |
| WALKER, Adam | Director | 2019-05-01 | 2020-03-02 |
| WALTERS, Peter Ingram, Sir | Director | — | 2000-12-31 |
| WENDT, Henry | Director | — | 1994-04-25 |
| WHITE, James | Director | — | 1994-06-24 |
| YAMADA, Tadataka, Doctor | Director | 1994-02-18 | 2005-08-05 |
| YOUNG, John Alan | Director | 1993-04-27 | 2000-12-31 |
| THE WELLCOME FOUNDATION LIMITED | Corporate Director | 2000-12-31 | 2002-09-05 |
| WELLCOME LIMITED | Corporate Director | 2000-12-31 | 2002-09-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Glaxosmithkline Finance Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 4006 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-09-29 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-08-15 | AA | accounts | accounts with accounts type full |
| 2024-11-07 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-09-23 | CH03 | officers | change person secretary company with change date |
| 2024-09-22 | AA | accounts | accounts with accounts type full |
| 2024-09-17 | CH01 | officers | change person director company with change date |
| 2024-09-11 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2024-09-11 | AD01 | address | change registered office address company with date old address new address |
| 2024-07-18 | AD02 | address | change sail address company with new address |
| 2023-10-25 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-08-22 | AA | accounts | accounts with accounts type full |
| 2023-08-16 | CH02 | officers | change corporate director company with change date |
| 2022-11-24 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-09-13 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-08-05 | AA | accounts | accounts with accounts type full |
| 2022-06-06 | RESOLUTIONS | resolution | resolution |
| 2022-06-06 | RESOLUTIONS | resolution | resolution |
| 2022-06-06 | CC04 | change-of-constitution | statement of companys objects |
| 2022-06-06 | MA | incorporation | memorandum articles |
| 2022-03-10 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.